Health
Patrys Limited Announces Publication of PAT-DX1 Preclinical Data in JCI – Insight – BioSpace
Patrys Limited, a therapeutic antibody development company, has announced the publication of preclinical data for its therapeutic…
Series of preclinical studies demonstrate the therapeutic potential of PAT-DX1, a first-in-class, synthetically lethal DNA-binding antibody in primary brain cancers and brain metastases.MELBOURNE–(BUSINESS WIRE)– Patrys Limited (ASX:PAB), a therapeutic…
Continue Reading
-
General23 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Noosa News17 hours agoThe only person detained at Brisbane’s Palestine rally
-
Business16 hours agoHow to turn $500 a month into $500,000 with ASX shares